Impact of BMI on CDK4/6 Inhibitors Efficacy and Safety in Advanced Breast Cancer
Impact of BMI on CDK4/6 Inhibitors Efficacy and Safety in Advanced Breast Cancer
Active, not recruiting · NCT06926088 · Registry updated 2025-04-13Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Impact of BMI on CDK4/6 Inhibitors Efficacy and Safety in Advanced Breast Cancer | Advanced Breast Cancer | Active, not recruiting | Not stated | 2025-04-13 | NCT06926088 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| The First Affiliated Hospital with Nanjing Medical University | 319 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Jiangsu Provincial People's Hospital | Nanjing | China | 21 |